KLHL28
gene geneOn this page
Also known as FLJ20081
Summary
KLHL28 (kelch like family member 28, HGNC:19741) is a protein-coding gene on chromosome 14q21.2, encoding Kelch-like protein 28 (Q9NXS3).
Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul3-RING ubiquitin ligase complex. Predicted to be active in cytoplasm.
Source: NCBI Gene 54813 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_017658
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19741 |
| Approved symbol | KLHL28 |
| Name | kelch like family member 28 |
| Location | 14q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20081 |
| Ensembl gene | ENSG00000179454 |
| Ensembl biotype | protein_coding |
| Entrez | 54813 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 14 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000355081, ENST00000396128, ENST00000553817, ENST00000556239, ENST00000556500, ENST00000557468, ENST00000579157, ENST00000894795, ENST00000894796, ENST00000894797, ENST00000894798, ENST00000945246, ENST00000945247, ENST00000945248, ENST00000945249
RefSeq mRNA: 2 — MANE Select: NM_017658
NM_001308112, NM_017658
CCDS: CCDS76675, CCDS9680
Canonical transcript exons
ENST00000396128 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001428996 | 44934115 | 44934558 |
| ENSE00001430091 | 44961846 | 44961947 |
| ENSE00001431921 | 44931333 | 44931541 |
| ENSE00002445140 | 44924324 | 44929191 |
| ENSE00003755734 | 44945030 | 44945928 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 97.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.9602 / max 285.8743, expressed in 1780 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 143037 | 18.7927 | 1780 |
| 143036 | 0.1676 | 63 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 97.46 | gold quality |
| sperm | CL:0000019 | 97.17 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.30 | silver quality |
| ileal mucosa | UBERON:0000331 | 91.78 | gold quality |
| visceral pleura | UBERON:0002401 | 91.32 | gold quality |
| parietal pleura | UBERON:0002400 | 90.11 | gold quality |
| gingival epithelium | UBERON:0001949 | 89.87 | gold quality |
| deltoid | UBERON:0001476 | 89.19 | gold quality |
| tibialis anterior | UBERON:0001385 | 89.08 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 89.06 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 88.93 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 88.90 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 88.81 | gold quality |
| endothelial cell | CL:0000115 | 88.77 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 88.52 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 88.25 | gold quality |
| thymus | UBERON:0002370 | 87.90 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.80 | gold quality |
| upper leg skin | UBERON:0004262 | 87.71 | gold quality |
| gingiva | UBERON:0001828 | 87.66 | gold quality |
| tibia | UBERON:0000979 | 87.53 | gold quality |
| oocyte | CL:0000023 | 87.41 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.39 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 87.24 | silver quality |
| bronchial epithelial cell | CL:0002328 | 86.87 | gold quality |
| biceps brachii | UBERON:0001507 | 86.81 | gold quality |
| vastus lateralis | UBERON:0001379 | 86.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.55 | gold quality |
| quadriceps femoris | UBERON:0001377 | 86.47 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 86.35 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 323.96 |
| E-ANND-3 | yes | 3.70 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
270 targeting KLHL28, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | KLHL28 | ENSDARG00000101676 |
| mus_musculus | Klhl28 | ENSMUSG00000020948 |
| rattus_norvegicus | Klhl28 | ENSRNOG00000004218 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KBTBD3 (ENSG00000182359), KLHL33 (ENSG00000185271)
Protein
Protein identifiers
Kelch-like protein 28 — Q9NXS3 (reviewed: Q9NXS3)
Alternative names: BTB/POZ domain-containing protein 5
All UniProt accessions (6): Q9NXS3, G3V2P9, G3V4Y0, G3V5Y9, J3KNY7, J3KRJ0
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NXS3-1 | 1 | yes |
| Q9NXS3-2 | 2 |
RefSeq proteins (2): NP_001295041, NP_060128* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011043 | Gal_Oxase/kelch_b-propeller | Homologous_superfamily |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
Pfam: PF00651, PF01344, PF07707
UniProt features (13 total): repeat 6, sequence conflict 3, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NXS3-F1 | 92.78 | 0.79 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 204 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GGGTGGRR_PAX4_03, USF_C, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, MYCMAX_01, OCT1_03, USF_01, DOUGLAS_BMI1_TARGETS_DN, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, MODULE_544, USF_02, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, CHANDRAN_METASTASIS_UP, GOBP_PROTEIN_CATABOLIC_PROCESS, GCCATNTTG_YY1_Q6
GO Biological Process (1): proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)
GO Molecular Function (2): ubiquitin-like ligase-substrate adaptor activity (GO:1990756), protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), Cul3-RING ubiquitin ligase complex (GO:0031463)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ubiquitin-dependent protein catabolic process | 1 |
| proteasomal protein catabolic process | 1 |
| enzyme-substrate adaptor activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
620 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL28 | FBXO28 | Q9NVF7 | 677 |
| KLHL28 | RNF166 | Q96A37 | 676 |
| KLHL28 | DORIP1 | Q4W4Y0 | 642 |
| KLHL28 | PRKN | O60260 | 553 |
| KLHL28 | TOGARAM1 | Q9Y4F4 | 524 |
| KLHL28 | GPHA2 | Q96T91 | 455 |
| KLHL28 | PRPF39 | Q86UA1 | 438 |
| KLHL28 | NAA25 | Q14CX7 | 410 |
| KLHL28 | PCNX1 | Q96RV3 | 392 |
| KLHL28 | RSRP1 | Q9BUV0 | 383 |
| KLHL28 | TVP23C | Q96ET8 | 370 |
| KLHL28 | BTBD18 | B2RXH4 | 369 |
| KLHL28 | A0A0A6YYB9 | A0A0A6YYB9 | 368 |
| KLHL28 | PRSS58 | Q8IYP2 | 366 |
| KLHL28 | FKBP3 | Q00688 | 348 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRKACB | PRKAR1A | psi-mi:“MI:0914”(association) | 0.790 |
| KLHL24 | CUL3 | psi-mi:“MI:0914”(association) | 0.730 |
| VAPB | FAM83G | psi-mi:“MI:0914”(association) | 0.730 |
| CUL3 | ENC1 | psi-mi:“MI:0914”(association) | 0.640 |
| CUL3 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.530 |
| CUL3 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.530 |
| rep | KLHL28 | psi-mi:“MI:0915”(physical association) | 0.490 |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| CUL3 | KLHL2 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL28 | PRKACB | psi-mi:“MI:0914”(association) | 0.350 |
| PADI6 | PER1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKAR1A | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL14 | ARHGAP32 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKAR1B | ZNF749 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB3 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL28 | APOA1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (46): KLHL14 (Affinity Capture-MS), IPP (Affinity Capture-MS), FBXL17 (Affinity Capture-MS), KLHL21 (Affinity Capture-MS), NUDCD3 (Affinity Capture-MS), KLHL28 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL24 (Affinity Capture-MS), KLHL13 (Affinity Capture-MS), AKAP11 (Affinity Capture-MS), CUL7 (Affinity Capture-MS), PRKACB (Affinity Capture-MS), KLHL28 (Affinity Capture-RNA), KLHL26 (Affinity Capture-MS), AKAP11 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8Q1W5, B0WWP2, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, E9Q4F2, O14682, O35709, O94889, P28575, P59280, Q08BL9, Q08DK3, Q0D2A9, Q16RL8, Q1ECZ2, Q1LYM6, Q2M0J9, Q4KLM4, Q53HC5, Q56A24, Q5R7B8, Q5RGB8, Q5ZKD9, Q6DFF6, Q6DFF7, Q6TDP3, Q6TDP4, Q6TFL4, Q6V595, Q7QGL0, Q8BRG6
Diamond homologs: A0A2R8Q1W5, A9JRD8, B0WWP2, B3DIV9, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, D3ZUU2, E0CZ16, E1B932, E7F6F9, E9Q4F2, F1LZ52, F1LZF0, F1MBP6, G3X9X1, O15062, O93567, O94889, O95198, P28575, P57790, Q04652, Q08DK3, Q13105, Q14145, Q16RL8, Q1ECZ2, Q2M0J9, Q2TBA0, Q3SWU4, Q3ZB90
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 22 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein ubiquitination | 5 | 10.9× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3036 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:44929092:T:C | donor_gain | 1.0000 |
| 14:44929202:T:C | acceptor_gain | 1.0000 |
| 14:44931330:TAC:T | donor_loss | 1.0000 |
| 14:44931331:ACCTG:A | donor_loss | 1.0000 |
| 14:44931332:C:A | donor_loss | 1.0000 |
| 14:44931537:CCACA:C | acceptor_gain | 1.0000 |
| 14:44931538:CACAC:C | acceptor_gain | 1.0000 |
| 14:44931540:CA:C | acceptor_gain | 1.0000 |
| 14:44931542:C:CC | acceptor_gain | 1.0000 |
| 14:44945925:CCAT:C | acceptor_gain | 1.0000 |
| 14:44945926:CAT:C | acceptor_gain | 1.0000 |
| 14:44945926:CATC:C | acceptor_gain | 1.0000 |
| 14:44945927:ATC:A | acceptor_loss | 1.0000 |
| 14:44945928:TC:T | acceptor_loss | 1.0000 |
| 14:44945929:C:CC | acceptor_gain | 1.0000 |
| 14:44945929:C:T | acceptor_loss | 1.0000 |
| 14:44945930:T:A | acceptor_loss | 1.0000 |
| 14:44995744:A:AG | acceptor_gain | 1.0000 |
| 14:44995745:G:GA | acceptor_gain | 1.0000 |
| 14:44995899:GCTG:G | donor_gain | 1.0000 |
| 14:44995900:CTGG:C | donor_loss | 1.0000 |
| 14:44995901:TGGTA:T | donor_loss | 1.0000 |
| 14:44995902:GGTA:G | donor_loss | 1.0000 |
| 14:44995903:G:GG | donor_gain | 1.0000 |
| 14:44995904:T:A | donor_loss | 1.0000 |
| 14:44995905:AAG:A | donor_loss | 1.0000 |
| 14:44999357:CAAAA:C | acceptor_loss | 1.0000 |
| 14:44999361:A:AC | acceptor_loss | 1.0000 |
| 14:44999497:GGTA:G | donor_gain | 1.0000 |
| 14:45006117:GGGAA:G | donor_gain | 1.0000 |
AlphaMissense
3759 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:44931369:A:G | W506R | 1.000 |
| 14:44931369:A:T | W506R | 1.000 |
| 14:44929057:G:T | R563S | 0.999 |
| 14:44929108:A:C | Y546D | 0.999 |
| 14:44929149:C:A | G532V | 0.999 |
| 14:44929149:C:T | G532D | 0.999 |
| 14:44931367:C:A | W506C | 0.999 |
| 14:44931367:C:G | W506C | 0.999 |
| 14:44931428:C:T | G486E | 0.999 |
| 14:44931478:C:A | R469S | 0.999 |
| 14:44931478:C:G | R469S | 0.999 |
| 14:44931479:C:A | R469M | 0.999 |
| 14:44931479:C:G | R469T | 0.999 |
| 14:44931508:C:A | W459C | 0.999 |
| 14:44931508:C:G | W459C | 0.999 |
| 14:44931510:A:G | W459R | 0.999 |
| 14:44931510:A:T | W459R | 0.999 |
| 14:44934139:C:T | G440E | 0.999 |
| 14:44934189:T:A | R423S | 0.999 |
| 14:44934189:T:G | R423S | 0.999 |
| 14:44934190:C:G | R423T | 0.999 |
| 14:44934219:C:A | W413C | 0.999 |
| 14:44934219:C:G | W413C | 0.999 |
| 14:44934221:A:G | W413R | 0.999 |
| 14:44934221:A:T | W413R | 0.999 |
| 14:44934527:A:G | W311R | 0.999 |
| 14:44934527:A:T | W311R | 0.999 |
| 14:44945060:C:T | G290E | 0.999 |
| 14:44945063:C:T | G289E | 0.999 |
| 14:44945156:A:G | L258P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000028703 (14:44932056 T>G), RS1000097293 (14:44938843 T>C), RS1000118011 (14:44953167 G>A), RS1000148447 (14:44934846 A>G), RS1000187931 (14:44951515 A>G), RS1000220859 (14:44932536 G>A), RS1000247260 (14:44932238 G>A), RS1000254155 (14:44952854 T>G), RS1000347698 (14:44946548 A>G), RS1000376650 (14:44939418 T>G), RS1000380654 (14:44963768 G>A), RS1000520823 (14:44939872 C>T), RS1000656741 (14:44939630 T>A,C), RS1000757424 (14:44957428 A>T), RS1000816678 (14:44926171 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 7 |
| sodium arsenite | affects methylation, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| beta-N-methylamino-L-alanine | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| testosterone undecanoate | affects cotreatment, decreases expression | 1 |
| quercitrin | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| methylparaben | increases expression | 1 |
| ferrous chloride | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Copper | increases expression, affects binding | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Mercuric Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.